SOFOSBUVIR & LEDIPASVIR

Embrace the reliability of our SOFOSBUVIR & LEDIPASVIR, a peerless solution tailored for addressing chronic Hepatitis C. Backed by over 15 years of expertise as an exporter, distributor, supplier, trader, and wholesaler, we proudly present top-tier options such as LEDIFOS LEDIPASVIR AND SOFOSBUVIR TABLETS, SOVIHEP SOFOSBUVIR TABLETS, and SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS. These outstanding products stand in spectacular demand for their efficacy, convenience, and superior composition tailored to diverse medical needs. Trusted for their exceptional antiviral action, they offer advantages such as a shortened treatment duration, a simplified once-a-day dosage, minimal side effects, and compatibility with various patient groups, while enhancing overall cure rates and quality of life. Customizable to meet both domestic needs across All India and international market demands, these medicines are available for a limited time to ensure exclusivity. With an incessant focus on quality and a commitment to upholding global standards, our formulations are crafted to remain the most reliable and effective in the market. Place your trust in these highly acclaimed and highly effective therapeutics, and experience the difference they bring to optimized health outcomes with their unparalleled performance.

LEDIFOS LEDIPASVIR AND SOFOSBUVIR TABLETS

MOQ : 1 Bottle

  • Appearance
  • Film-coated tablets
  • Assay
  • >= 99% (by HPLC)
  • CAS No
  • 1256388-51-8 (Ledipasvir), 1190307-88-0 (Sofosbuvir)
  • Dosage
  • 90 mg Ledipasvir/400 mg Sofosbuvir
  • Dosage Form
  • Tablet
  • Expiration Date
  • 24-36 months from date of manufacture
  • Grade
  • Pharmaceutical Grade
  • Indication
  • Chronic hepatitis C infection (genotype 1, 4, 5, and 6)
  • Medicine Type
  • Allopathic
  • Molecular Formula
  • Ledipasvir (C49H54F2N8O6), Sofosbuvir (C22H29FN3O9P)
  • Origin of Medicine
  • India
  • Pacakaging (Quantity Per Box)
  • 28 Tablets (1 tablet per strip, 28 strips per box)
  • Salt Composition
  • Ledipasvir 90 mg and Sofosbuvir 400 mg
  • Storage
  • Store below 30C, protect from moisture
  • Usage
  • For the treatment of chronic hepatitis C virus (HCV) infection
LEDIFOS LEDIPASVIR & SOFOSBUVIR

SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS

  • Appearance
  • Film-coated tablets
  • Assay
  • Not less than 98% (as per label claim)
  • CAS No
  • 1190307-88-0 (Sofosbuvir), 1256388-51-8 (Ledipasvir)
  • Dosage
  • 400 mg Sofosbuvir + 90 mg Ledipasvir
  • Dosage Form
  • Tablet
  • Expiration Date
  • 36 months from manufacturing date
  • Grade
  • Pharmaceutical Grade
  • Indication
  • Chronic Hepatitis C Virus (HCV) infection
  • Medicine Type
  • Allopathic
  • Molecular Formula
  • Sofosbuvir: C22H29FN3O9P; Ledipasvir: C49H54N8O6
  • Origin of Medicine
  • India
  • Pacakaging (Quantity Per Box)
  • 28 tablets per box
  • Salt Composition
  • Sofosbuvir 400 mg + Ledipasvir 90 mg
  • Storage
  • Store below 30C, protect from moisture and light
  • Usage
  • For the treatment of chronic hepatitis C infection
SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS

SOVIHEP SOFOSBUVIR TABLETS

MOQ : 100 Boxes

  • Appearance
  • Tablet
  • Dosage
  • As Per Suggestion
  • Grade
  • Pharma
  • Origin of Medicine
  • India
  • Storage
  • Cool & Dry place
  • Usage
  • Industrial
SOVIHEP SOFOSBUVIR TABLETS


Back to top